Загрузка...
NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma
The prognosis for patients with glioblastoma is grim. Ex vivo expanded tumor-associated antigen (TAA)-reactive T-cells from patients with glioma may represent a viable source for anticancer-directed cellular therapies. Immunohistochemistry was used to test the survivin (n = 40 samples) and NY-ESO-1...
Сохранить в:
| Опубликовано в: : | Cancer Immunol Immunother |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Berlin Heidelberg
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5799356/ https://ncbi.nlm.nih.gov/pubmed/29058035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-017-2066-z |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|